Placement Completed

Obsidian Therapeutics placement

US$350m raised

Announced 14 Apr 2026 · NASDAQ: OBX

Advisers

Issuer
Obsidian Therapeutics
Issuer based in
United States
Completed
3 Aug 2026
Sector
Biotech
Tags
Biotech, Cell Therapy, Oncology

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.